Cetrorelix

From WikiMD.org
Jump to navigation Jump to search

Cetrorelix

Cetrorelix (/sɛˈtrɔːrɪlɛks/) is a synthetic decapeptide with potent gonadotropin-releasing hormone (GnRH) antagonist properties. It is primarily used in assisted reproduction to control ovulation.

Etymology

The name "Cetrorelix" is derived from the chemical structure of the drug. "Cetro" is a prefix used in chemistry to denote a compound with four substituents, referring to the four amino acids in the peptide chain of Cetrorelix. "Relix" is a suffix used in pharmacology to denote a drug that acts as a receptor antagonist, indicating the drug's mechanism of action.

Usage

Cetrorelix is used in assisted reproductive technologies (ART) to prevent premature ovulation in women undergoing controlled ovarian hyperstimulation. It allows for the timing of the final maturation of the eggs and their subsequent collection for in-vitro fertilization (IVF).

Mechanism of Action

Cetrorelix works by blocking the action of gonadotropin-releasing hormone (GnRH) on the pituitary gland. This prevents the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), thereby inhibiting ovulation.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski